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Background
Recent studies have demonstrated the potential of in
vivo diffusion-weighted MRI (DWI) in detecting myo-
cardial replacement fibrosis for chronic myocardial
infarction [1-3]. Despite the potential of this contrast-
free technique, detecting diffuse myocardial fibrosis with
DWI has not been established. Current cardiac MRI
(CMR) techniques to detect diffuse myocardial fibrosis
include late gadolinium enhancement (LGE) [4], pre/
post contrast T1 mapping [5], and extracellular volume
(ECV) mapping [6]. We propose the application of a
recently developed cardiac DWI technique [7] to detect
diffuse myocardial fibrosis in HCM patients and com-
pare its performance with established CMR techniques.
Methods
HCM patients (N = 23) were recruited and consented
under Institutional Review Board. All patients were
scanned on a 1.5T Siemens Avanto with the following
protocol: standard morphological localizers, DWI (3
orthogonal diffusion directions, b = 350 s/mm^2, free
breathing) and pre/post contrast T1 mapping (MOLLI,
TImin = 100ms, TIinc = 80msec, breath-hold). ADC was
calculated using a monoexponential fit. ECV was calcu-
lated by fitting pre/post T1 values of the myocardium
and blood pool with a collected hematocrit percentage
[6]. All images were acquired in the short axis view with
matching slice positions. ADC and ECV images were
segmented into 6 American Heart Association (AHA)
segments. Positive regions for myocardial fibrosis were
defined as: ADC > 2.0 μm2/ms [1] and ECV > 30% [8].
For ADC and ECV, a two-sample t-test was performed
to evaluate the difference between mean values of fibro-
tic and non-fibrotic regions. To test for agreement in
regional detection, Cohen’s Kappa test was performed
along with calculating sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV) using ECV as the gold-standard reference.
Results
ADC of fibrotic regions (2.4 ± 0.2 μm2/ms) was signifi-
cantly (p<0.01) higher than ADC of non-fibrotic regions
(1.5 ± 0.2 μm2/ms) (Fig 1, 2). Similarly, ECV of fibrotic
regions (35 ± 4%) was significantly (p<0.01) higher than
ECV of non-fibrotic regions (26 ± 2%). In fibrotic
regions defined by ECV, ADC (2.2 ± 0.3 μm2/ms) was
again significantly (p< 0.05) higher than ADC of non-
fibrotic regions (1.6 ± 0.3 μm2/ms). In fibrotic regions
defined by ADC criterion, ECV (34 ± 5%) was signifi-
cantly (p < 0.01) higher than ECV in non-fibrotic
regions (28 ± 3%). Regional detection between ADC and
ECV of diffuse fibrosis yielded substantial agreement (
= 0.66) with high sensitivity, specificity, PPV, NPV, and
accuracy (0.80, 0.85, 0.81, 0.85, and 0.83, respectively).
Conclusions
Cardiac DWI is sensitive to diffuse myocardial fibrosis





1Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los
Angeles, CA, USA. 2Bioengineering, University of California Los Angeles, Los
Angeles, CA, USA. 3State Key Laboratory of Cardiovascular Disease, Fuwai
1Biomedical Imaging Research Institute, Cedars-Sinai Medical Center, Los
Angeles, CA, USA
Full list of author information is available at the end of the article
Nguyen et al. Journal of Cardiovascular Magnetic
Resonance 2015, 17(Suppl 1):P34
http://www.jcmr-online.com/content/17/S1/P34
© 2015 Nguyen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Hospital, Beijing, China. 4National Center for Cardiovascular Diseases, Chinese
Academy of Medical Sciences and Peking Union Medical College, Beijing,
China. 5National Heart, Lung, and Blood Institute, National Institutes of
Health, Bethesda, MD, USA. 6MR R&D, Siemens Healthcare, Los Angeles, CA,
USA.
Published: 3 February 2015
References
1. Nguyen , et al: JCMR 2014.
2. Pop , et al: PMB 2013.
3. Wu , et al: MRM 2007.
4. Moravsky , et al: JACC 2013.
5. Moon , et al: JCMR 2013.
6. Kellman , et al: JCMR 2012.
7. Nguyen , et al: MRM 2013.
8. Kellman , et al: JCMR 2012.
doi:10.1186/1532-429X-17-S1-P34
Cite this article as: Nguyen et al.: In vivo diffusion-weighted mri
detection of myocardial fibrosis in hypertrophic cardiomyopathy
patients. Journal of Cardiovascular Magnetic Resonance 2015 17(Suppl 1):
P34.
Figure 1 ADC and ECV in fibrosis and non-fibrosis regions defined by either ADC > 2 um^2/ms or ECV > 30% were compared. Both ADC and
ECV were significantly (p < 0.01) higher in fibrosis than non-fibrosis regions for both criteria.
Figure 2 Representative example of ADC and ECV maps with associated AHA wheels. LGE is provided for qualitative reference. Qualitatively, the
ADC and ECV maps are in agreement with matching endocardial presentation of fibrosis in the anterior and anteriolateral AHA segments. This is
further substantiated quantitatively with excellent agreement in the AHA wheels.
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